000 | 02020 a2200541 4500 | ||
---|---|---|---|
005 | 20250515120941.0 | ||
264 | 0 | _c20080815 | |
008 | 200808s 0 0 eng d | ||
022 | _a1873-2402 | ||
024 | 7 |
_a10.1016/j.biopsych.2008.03.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCarter, Cameron S | |
245 | 0 | 0 |
_aIdentifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. _h[electronic resource] |
260 |
_bBiological psychiatry _cJul 2008 |
||
300 |
_a4-10 p. _bdigital |
||
500 | _aPublication Type: Consensus Development Conference; Consensus Development Conference, NIH; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 | _aBiomedical Research |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCognition Disorders _xdiagnosis |
650 | 0 | 4 | _aCooperative Behavior |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNational Institute of Mental Health (U.S.) |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 | _aResearch Support as Topic |
650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
650 | 0 | 4 | _aSchizophrenic Psychology |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aBarch, Deanna M | |
700 | 1 | _aBuchanan, Robert W | |
700 | 1 | _aBullmore, Ed | |
700 | 1 | _aKrystal, John H | |
700 | 1 | _aCohen, Jonathan | |
700 | 1 | _aGeyer, Mark | |
700 | 1 | _aGreen, Michael | |
700 | 1 | _aNuechterlein, Keith H | |
700 | 1 | _aRobbins, Trevor | |
700 | 1 | _aSilverstein, Steven | |
700 | 1 | _aSmith, Edward E | |
700 | 1 | _aStrauss, Milton | |
700 | 1 | _aWykes, Til | |
700 | 1 | _aHeinssen, Robert | |
773 | 0 |
_tBiological psychiatry _gvol. 64 _gno. 1 _gp. 4-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2008.03.020 _zAvailable from publisher's website |
999 |
_c17962167 _d17962167 |